104 related articles for article (PubMed ID: 12792903)
1. Interleukin-7 (IL-7) and IL-7 receptor (IL-7R) signalling complex in human solid tumours.
Al-Rawi MA; Mansel RE; Jiang WG
Histol Histopathol; 2003 Jul; 18(3):911-23. PubMed ID: 12792903
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of interleukin-7 (IL-7) and its signalling complex in human breast cancer.
Al-Rawi MA; Rmali K; Watkins G; Mansel RE; Jiang WG
Eur J Cancer; 2004 Mar; 40(4):494-502. PubMed ID: 14962714
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-7 receptor expression and activation in nonhaematopoietic neoplastic cell lines.
Cosenza L; Gorgun G; Urbano A; Foss F
Cell Signal; 2002 Apr; 14(4):317-25. PubMed ID: 11858939
[TBL] [Abstract][Full Text] [Related]
5. Differential association of phosphatidylinositol 3-kinase with insulin receptor substrate (IRS)-1 and IRS-2 in human thymocytes in response to IL-7.
Sharfe N; Roifman CM
J Immunol; 1997 Aug; 159(3):1107-14. PubMed ID: 9233603
[TBL] [Abstract][Full Text] [Related]
6. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
Doucet C; Giron-Michel J; Canonica GW; Azzarone B
Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-7: physiological roles and mechanisms of action.
Hofmeister R; Khaled AR; Benbernou N; Rajnavolgyi E; Muegge K; Durum SK
Cytokine Growth Factor Rev; 1999 Mar; 10(1):41-60. PubMed ID: 10379911
[TBL] [Abstract][Full Text] [Related]
8. Signalling by cytokines interacting with the interleukin-2 receptor gamma chain.
Demoulin JB; Renauld JC
Cytokines Cell Mol Ther; 1998 Dec; 4(4):243-56. PubMed ID: 10068058
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
Badache A; Hynes NE
Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
[TBL] [Abstract][Full Text] [Related]
10. IL-7/IL-7 receptor system regulation following IL-2 immunotherapy in HIV-infected patients.
Marchetti G; Meroni L; Molteni C; Taskaris G; Gazzola L; Galli M; Clerici M; Moroni M; Franzetti F; Gori A
Antivir Ther; 2004 Jun; 9(3):447-52. PubMed ID: 15259908
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells.
Marzec M; Halasa K; Kasprzycka M; Wysocka M; Liu X; Tobias JW; Baldwin D; Zhang Q; Odum N; Rook AH; Wasik MA
Cancer Res; 2008 Feb; 68(4):1083-91. PubMed ID: 18281483
[TBL] [Abstract][Full Text] [Related]
12. IL-7 receptor α expressing B cells act proinflammatory in collagen-induced arthritis and are inhibited by sympathetic neurotransmitters.
Pongratz G; Anthofer JM; Melzer M; Anders S; Grässel S; Straub RH
Ann Rheum Dis; 2014 Jan; 73(1):306-12. PubMed ID: 23505234
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-7 induces the association of phosphatidylinositol 3-kinase with the alpha chain of the interleukin-7 receptor.
Venkitaraman AR; Cowling RJ
Eur J Immunol; 1994 Sep; 24(9):2168-74. PubMed ID: 7522165
[TBL] [Abstract][Full Text] [Related]
14. Exploiting differential expression of the IL-7 receptor on memory T cells to modulate immune responses.
Zaunders JJ; Lévy Y; Seddiki N
Cytokine Growth Factor Rev; 2014 Aug; 25(4):391-401. PubMed ID: 25130296
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-7 activates p56lck and p59fyn, two tyrosine kinases associated with the p90 interleukin-7 receptor in primary human T cells.
Page TH; Lali FV; Foxwell BM
Eur J Immunol; 1995 Oct; 25(10):2956-60. PubMed ID: 7589097
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-2 (IL-2) receptor-betagamma signalling is activated by c-Kit in the absence of IL-2, or by exogenous IL-2 via JAK3/STAT5 in human papillomavirus-associated cervical cancer.
Rocha-Zavaleta L; Huitron C; Cacéres-Cortés JR; Alvarado-Moreno JA; Valle-Mendiola A; Soto-Cruz I; Weiss-Steider B; Rangel-Corona R
Cell Signal; 2004 Nov; 16(11):1239-47. PubMed ID: 15337523
[TBL] [Abstract][Full Text] [Related]
17. Regulation of JAK3 expression and activation in human B cells and B cell malignancies.
Tortolani PJ; Lal BK; Riva A; Johnston JA; Chen YQ; Reaman GH; Beckwith M; Longo D; Ortaldo JR; Bhatia K; McGrath I; Kehrl J; Tuscano J; McVicar DW; O'Shea JJ
J Immunol; 1995 Dec; 155(11):5220-6. PubMed ID: 7594533
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 7 induces the growth of breast cancer cells through a wortmannin-sensitive pathway.
Al-Rawi MA; Rmali K; Mansel RE; Jiang WG
Br J Surg; 2004 Jan; 91(1):61-8. PubMed ID: 14716795
[TBL] [Abstract][Full Text] [Related]
19. The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells.
Al-Rawi MA; Watkins G; Mansel RE; Jiang WG
Int J Oncol; 2005 Sep; 27(3):721-30. PubMed ID: 16077922
[TBL] [Abstract][Full Text] [Related]
20. Activation of phosphatidylinositol-3 kinase by ligation of the interleukin-7 receptor on human thymocytes.
Dadi HK; Roifman CM
J Clin Invest; 1993 Sep; 92(3):1559-63. PubMed ID: 8397227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
